Ambulatory Surgical and Emergency Centers Market By Service Type (Orthopedics, Ophthalmology, Gastroenterology, Plastic Surgery, Pain Management or Spinal Injections, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 190

The global ambulatory surgical and emergency centers market is expected to grow at a CAGR of 6.2% over the forecast period 2019 to 2026 and market size is poised to reach US$ 203.1 Bn by 2026.

Ambulatory surgery and emergency centers are medical care facilities that provide same-day surgery care which also includes consultation and diagnosis. It is a more convenient alternative to hospital based outpatient procedures. Various specialties serve in ambulatory surgery and emergency centers are ophthalmology, orthopedics, gastroenterology, plastic Surgery, pain, gynecology, and many others. Physicians have taken the lead for the development of ambulatory service centers to improve patient care, quality, and cost-effectivity. First facility was opened in 1970 in the U.S. With the increasing burden on healthcare facilities, hospitals were facing several challenges such as limited operating room, scheduling delays, and difficulties for obtaining new medical devices or equipment due to low hospital budgets, which is responsible for the development of ambulatory service centers.           

Market Dynamics

According to the Ambulatory Surgery Center Association (ASCA), surgeries performed in ASCs are around 50.0% economical than Hospital Outpatient Department (HOPD). Preventive treatment and the significant cost reduction are anticipated to boost the utility of ASC in the coming years. Availability of funding for ambulatory healthcare facilities and supportive government initiatives are also anticipated to propel the market growth in the coming years. Technological advancements in minimally invasive surgeries and its growing demand due to increasing awareness and shorten hospital stay; thereby lower expenditure will drive the market further during the forecast period. For instance, the development of endoscopy and laparoscopy has reduced the need for longer hospital stays.

Governments across the world are investing more in primary healthcare facilities to provide accessible medical care and decrease the burden on hospitals. For instance, in February 2016, NHS introduced the reforms, which include the provision of enhanced funding to general physicians to ease the pressure on emergency and accident departments, boosted the prospects of Primary Healthcare Properties (PHP). Various business strategies undertaken by key operating players and investment firms are also anticipated to boost the market growth in coming years. These strategies include mergers and acquisitions, geographic expansion, and product launches.

Recruiting new independent surgeons, increasing number of surgeries as Centers for Medicare & Medicaid Services (CMS) keeps expanding the list of ASC-qualified procedures, and technological limitations are the major restraints of the ambulatory surgery and emergency centers market. 

Based on type of service, ambulatory surgical and emergency centers market categorized into orthopedics, ophthalmology, gastroenterology, plastic surgery, pain management or spinal injections, and others. Plastic surgery is anticipated to observe the fastest growth during the forecast period due to increasing awareness about safety of surgery and development in minimally invasive field. For instance, according to the American Society of Plastic Surgeons (ASPS) published report, about two hundred fifty thousand more cosmetic procedures were performed in 2018 as compared to previous year. According to the ASPS, in 2018, more than 17.7 million minimally invasive and surgical procedures were performed in the U.S. The gastroenterology segment dominated the market in 2018 due to large number of surgical procedures across the world. Development in the field of colonoscopy and endoscopy and high demand of procedures due to rising gastrointestinal disorders are some of the factors responsible for the dominance of the gastroenterology segment in the market.    .

North America dominated the global ambulatory surgical and emergency centers market in 2018 and is anticipated to observe its dominance during the forecast period. High awareness about ambulatory surgery centers, supportive government initiatives for quality and cost effective patient care, and availability of reimbursement for ambulatory surgery and emergency centers are the key factors for the dominance of the region. According to the Definitive Healthcare published data, there are more than 9,280 ambulatory surgery centers across the U.S. Easy access to these facilities due to wide range of network is also expected to boost the market growth. Asia Pacific is anticipated to grow at the fastest rate during the forecast period due to increasing geriatric population, growing awareness about cost effectiveness of ambulatory surgical centers, affiliation of ASCs to insurance companies, and development in minimally invasive procedures. 

The market research study on “Ambulatory Surgical and Emergency Centers Market – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026”, offers a detailed insight on the global ambulatory surgical and emergency centers market entailing insights on its different market segments. Market dynamics with drivers, restraints, and opportunities with their impact are provided in the report. The report provides insights into the global ambulatory surgical and emergency centers market, its type, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global ambulatory surgical and emergency centers market size and segment markets by type, and geography along with the information on companies operating in the market. The ambulatory surgical and emergency centers market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa. For each region, the market sizes for different segments have been covered under the scope of the report.  

The players profiled in the report include Tenet Healthcare Corporation; Envision Healthcare Corporation; Terveystalo; IntegraMed America, Inc.; Somerset Ambulatory Surgical Center, Center For Ambulatory Surgery, and Medical Facilities Corporation. Collaborations, acquisitions, and mergers of the health care providers to expand services offerings and geographical footprints are the key strategies being adopted by the market players.

Market Segmentation

By Service Type

  • Orthopedics
  • Ophthalmology
  • Gastroenterology
  • Plastic Surgery
  • Pain Management or Spinal Injections
  • Others

By Geography

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa


Related Reports

Next Generation sequencing Market (By Products and Services: NGS Platforms & Related Products, NGS Services; By Application: Oncology, Reproductive Health, Clinical Investigation, Immune System Monitoring, Agriculture & Animal Research, Epidemiology & Drug Development, Consumer Genomics; By Technology: Whole Genome Sequencing, Targeted Sequencing & Resequencing, Whole Exome Sequencing; By End Users: Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other users) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The Global Next Generation Sequencing Market is expected to grow at a CAGR of around 18.7% over the forecast period 2019 to 2026 and poised to reach around US$ 20.4 Bn by 2026. Next Generation Sequencing (NGS) is a platform that enabled the sequencing of thousands to millions DNA molecules simultaneously. It is also known as the massively parallel sequencing technology. This sequencing helps in the various fie

Ultrasound Equipment Market (By Portability: Trolley/Cart-based, Compact, Handheld; By Application: Obstetrics/Gynecology, General Imaging, Vascular Applications, Cardiologic Applications, Orthopedic Applications, Urological Applications, Pain Management, Others; By Equipment Display: Black & White, Color; By Technology: Therapeutic, Diagnostic) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ultrasound equipment market is expected to grow at a CAGR of around 6.3% from 2019 to 2026 and expected to reach the market value of around US$ 10 Bn by 2026. Ultrasound is a medical imaging technology that uses sound waves to produce pictures of body’s inside part. It helps to diagnose swelling, pain, and infection in internal organs and to examine a baby in pregnant women. Ultrasound is also

Minimally Invasive Surgery Market (By Product: Handheld Instruments, Electrosurgical Instruments, Guiding Devices, Inflation Systems, Auxiliary Instruments, Cutter Instruments; By Application: Gastrointestinal Surgery, Cardiothoracic Surgery, Orthopedic Surgery, Gynecological Surgery, Cosmetic/Bariatric Surgery, Vascular Surgery, Urological Surgery, Others; By End User: Hospitals, Ambulatory Surgery Centers, Research Institutes) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global minimally invasive surgery market is expected to grow at a CAGR of around 9.6% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 33.8 Bn by 2026. Minimally invasive surgery uses techniques to operate with less incision or damage to the body than open surgery. Hence, it is associated with less pain, fewer postoperative complications, and short

Implantable Medical Devices Market (By Product: Dental Implants, Breast Implants, Orthopedic Implants, Cardiovascular Implants, Intraocular Lens, Others) - Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global implantable medical devices market is expected to grow at a CAGR of around 7.3% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 153.8 Bn by 2026. An implant is a medical device, manufactured to support or replace any damaged organs in the body, treat imperfections in normal body functions, or enhance the functioning of body organs. These can be implanted by

eClinical Solutions Market (By Product: Electronic Data Capture and Clinical Data Management Systems, Clinical Trial Management Systems; By Delivery Mode: Web-Hosted (On-Demand) Solutions, Licensed Enterprise (On-Premise) Solutions, Cloud-Based (SaaS) Solutions; By Clinical Trial Phase: Phase I Clinical Trials, Phase II Clinical Trials; By End-Use: Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The Global eclinical Solutions Market is expected to grow at a CAGR of around 9.7% from 2019 to 2026 and expected to reach the market value of around US$ 9,756 Mn by 2026. The eclinical solutions refer to the development and offering of clinical technologies and expertise which are aimed at supporting the development of the clinical process. The eclinical solutions usually involve

Insulin Delivery Devices Market (By Type: Insulin Syringe, Insulin Pens, Insulin Jet Injectors, Insulin Pumps, Insulin Needles, Insulin Inhalers; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics & Centers; By End Use: Hospitals, Clinics, Ambulatory Care Centers, Homecare) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The Global Insulin Delivery Devices Market value is expected to reach around US$ 22.5 Bn by 2026 and growing at a CAGR of around 7.2% over the forecast period 2019 to 2026. Insulin delivery devices are used to deliver insulin to patients with Type 1 and Type 2 diabetes. Insulin is an important part of treatment for the diabetes patient which helps them to get glucose from the blood

Cart Summary